| Trial ID: | L3179 |
| Source ID: | NCT00962065
|
| Associated Drug: |
Lx4211 Low Dose
|
| Title: |
Study of LX4211 in Subjects With Type 2 Diabetes Mellitus
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT00962065/results
|
| Conditions: |
Type 2 Diabetes Mellitus
|
| Interventions: |
DRUG: LX4211 Low Dose|DRUG: LX4211 High Dose|DRUG: Placebo
|
| Outcome Measures: |
Primary: Change From Baseline at Day 28 in 24-hour Urinary Glucose Excretion, To assess 24-hour urinary glucose excretion, urine was collected over a 24-hour period and evaluated for glucose concentration., Baseline to Day 28 | Secondary: Change From Baseline at Day 29 in Fasting Plasma Glucose, Baseline to Day 29|Change From Baseline at Day 28 in Plasma HbA1c, Baseline to Day 28|Change From Baseline at Day 28 in Plasma Fructosamine Level, Baseline to Day 28|Change From Baseline at Day 28 in Mean Arterial Pressure, Baseline to Day 28|Change From Baseline at Day 28 in Triglycerides, Baseline to Day 28
|
| Sponsor/Collaborators: |
Sponsor: Lexicon Pharmaceuticals
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
36
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2009-08
|
| Completion Date: |
|
| Results First Posted: |
2011-03-03
|
| Last Update Posted: |
2011-03-03
|
| Locations: |
Lexicon Investigational Site, San Antonio, Texas, 78209, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00962065
|
